查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1406414

腫瘤資訊系統市場 - 全球產業規模、佔有率、趨勢、機會和預測，按產品和服務、按應用、最終用戶、地區和競爭細分，2018-2028

Oncology Information System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product & Services, By Application, By End User, By Region, and By Competition, 2018-2028
出版日期: | 出版商: TechSci Research | 英文 183 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球腫瘤資訊系統 (OIS) 市場正在經歷顯著的成長和轉型，因為它在現代癌症護理中發揮越來越重要的作用。 OIS 是一款整合式軟體解決方案，旨在管理腫瘤治療和患者資料的複雜和多方面問題。該市場由幾個關鍵因素推動，包括全球癌症負擔不斷增加、對更有效率和個人化癌症護理的需求、技術進步以及數據驅動決策在醫療保健領域日益重要。

OIS 系統提供廣泛的功能，包括病患資料管理、治療計劃、日程安排、計費和報告。它們促進參與癌症治療的醫療保健專業人員之間的無縫溝通和協作，從而實現更全面和協調的護理。此外，OIS 解決方案透過提供治療計劃驗證、劑量驗證和品質保證工具來提高癌症治療的品質和安全性。

隨著對改善癌症護理的需求不斷成長，OIS 系統正在成為全球腫瘤診所、醫院和研究機構不可或缺的組成部分。他們支持醫療保健提供者提供基於證據和以患者為中心的護理，確保癌症患者接受最合適和有效的治療。此外，OIS 平台透過支援患者資料和研究結果的管理，為癌症研究的進步做出了貢獻。

市場概況
預測期 2024-2028
2022 年市場規模 30.3億美元
2028 年市場規模 48.2億美元
2023-2028 年CAGR 7.16%
成長最快的細分市場 專業服務
最大的市場 北美洲

該市場的特點是提供 OIS 解決方案的供應商多種多樣，從成熟的醫療 IT 公司到專業的腫瘤軟體提供者。這些公司競相創新和增強其產品，引入人工智慧、機器學習和互通性等功能，以進一步提高癌症護理的準確性和效率。

成本和資源限制：

對於醫療機構來說，實施和維護先進的 OIS 可能需要大量資金，特別是預算有限的小型診所和設施。平衡對尖端 OIS 功能的需求與預算限制是一個持續的挑戰。

監理合規性：

醫療保健產業受到眾多法規和合規要求的約束，包括與病患資料保護相關的法規和合規要求（例如美國的 HIPAA）。 OIS 提供者和醫療機構必須持續監控並適應不斷變化的監管框架，這些框架可能很複雜，並且因地區而異。

新興科技的整合：

OIS 必須跟上醫療保健技術的快速發展，包括人工智慧 (AI)、機器學習 (ML) 和基因組學。有效整合這些新興技術，同時確保其臨床有效性是一項挑戰。此外，培訓醫療保健專業人員使用這些先進工具也至關重要。

主要市場趨勢

人工智慧和機器學習 (ML) 的整合：

人工智慧和機器學習透過分析大量患者資料集來識別趨勢、預測結果和最佳化治療計劃，正在徹底改變腫瘤學資訊系統。這些技術幫助腫瘤科醫師做出數據驅動的決策、加強病患照護並提高治療效果。

遠距醫療和遠端監控：

COVID-19 大流行加速了腫瘤學中遠距醫療和遠端監測的採用。腫瘤學資訊系統現在配備了遠距醫療功能，允許患者遠端諮詢腫瘤科醫生。這種趨勢確保了持續照護並最大限度地減少干擾，特別是對於接受長期治療的患者。

個人化醫療和基因組數據整合：

基因組學的進步促進了腫瘤學個人化醫療的發展。腫瘤學資訊系統現在整合基因組資料，根據患者的基因譜量身訂做治療計畫。這種方法可以提高治療效果並最大限度地減少副作用。

基於雲端的解決方案和資料可存取性：

基於雲端的腫瘤學資訊系統提供安全儲存、輕鬆存取以及醫療保健提供者之間的無縫資料共享。這種趨勢促進了協作，降低了基礎設施成本，並確保患者資料保持最新並可從任何地方存取。

患者參與和倖存者護理計劃：

腫瘤學資訊系統擴大融入讓患者積極參與護理的功能。倖存者照護計畫對於幫助患者從治療無縫過渡到後續照護變得越來越重要。這些計劃也為患者提供了長期生存所需的資訊和資源。

細分市場洞察

產品與服務見解

到 2022 年，軟體領域將在全球腫瘤資訊系統市場中佔據主導地位。OIS 軟體旨在高效收集、儲存和管理對腫瘤治療至關重要的大量患者資料。這包括患者病史、影像資料（例如 MRI 和 CT 掃描）、實驗室結果和治療計劃。即時集中和存取這些資訊的能力可以增強臨床決策。

OIS 軟體提供先進的治療計劃工具，幫助腫瘤科醫師為患者制定量身定做的治療方案。這些系統使用先進的演算法來分析患者資料，幫助醫療保健提供者確定最合適的治療和介入措施。治療計劃對於提高治療效果和盡量減少副作用至關重要。

OIS 軟體透過自動化管理任務、預約安排和資料輸入來簡化腫瘤學工作流程。這種效率使醫療保健專業人員能夠更多地關注患者護理，而不是文書工作，最終提高生產力。

OIS 軟體與其他醫療保健 IT 系統無縫整合，例如電子健康記錄 (EHR) 和放射資訊系統 (RIS)，確保醫療機構內不同部門之間的資訊無縫流動。這種整合增強了護理協調並降低了錯誤風險。

OIS 軟體提供強大的資料分析和報告功能。它允許醫療保健提供者追蹤患者結果、評估治療效果並進行研究。分析癌症治療的趨勢和模式可以導致治療方案的不斷改進。

應用洞察

到2022年，放射腫瘤學領域將在全球腫瘤學資訊系統市場中佔據主導地位。放射治療在癌症治療中發揮關鍵作用，精準度至關重要。放射腫瘤學領域內的 OIS 系統經過專門設計，可確保準確的治療計畫。它們結合了 CT 掃描和 MRI 等先進的影像技術，可以精確瞄準腫瘤，同時最大限度地減少對周圍健康組織的損害。這種精度水平對於放射治療至關重要。

OIS 放射腫瘤學解決方案能夠根據每位患者獨特的解剖結構和狀況制定高度個人化的治療計劃。他們考慮腫瘤大小、位置和對先前治療的反應等因素，確保最佳化放射治療以獲得最大效果。

放射治療依賴於計算最佳放射劑量來消滅癌細胞，同時保護健康組織。 OIS 軟體在劑量計算和最佳化方面表現出色，可確保患者接受適量的輻射，從而以最小的副作用實現治療目標。

放射腫瘤學部分包括即時治療監測和實施的功能。 OIS 系統提供保障措施，以驗證每次治療期間是否準確提供規定的輻射劑量，讓患者和臨床醫生安心。

在放射腫瘤學中，病人安全至關重要。該領域的 OIS 解決方案結合了安全檢查和品質保證協議，以最大限度地減少治療過程中出現錯誤的風險。它們還有助於遵守嚴格的監管標準和準則。

放射腫瘤學 OIS 軟體與 PET/CT、MRI 和直線加速器等影像系統無縫整合。這種整合確保治療計劃基於最新的患者資料和成像結果，從而提高放射治療的精確度。

區域洞察

到 2022 年，北美將主導全球腫瘤資訊系統市場。北美擁有高度發展、技術先進的醫療基礎設施。該地區擁有一些世界領先的癌症治療中心、研究機構和醫療機構。最先進的設備和熟練的勞動力使其成為採用 OIS 的沃土。

北美的癌症發生率相對較高。據美國癌症協會稱，癌症是美國的主要原因之一。該地區癌症的流行促使醫療保健提供者投資 OIS 等先進解決方案，以有效管理患者資料、治療計劃和結果。

北美一直處於個人化醫療運動的最前沿，該運動根據個別患者的情況量身定做癌症治療方法。 OIS 在收集和分析患者特定資料（包括遺傳資訊和生物標記）以指導個人化治療決策方面發揮著至關重要的作用。該地區對推動個人化醫療的承諾推動了對 OIS 解決方案的需求。

北美承擔著全球腫瘤學研究和臨床試驗的很大一部分。該地區的學術機構、製藥公司和醫療保健提供者積極參與臨床研究。 OIS 促進了臨床試驗患者資料的管理，使其成為參與癌症研究的研究人員和機構不可或缺的工具。

北美擁有完善的監管機構，例如美國食品藥物管理局 (FDA) 和加拿大衛生部，它們為 OIS 等醫療保健 IT 系統提供了明確的指導方針和法規。監管框架確保 OIS 解決方案的安全性和有效性，為醫療保健提供者註入信心並鼓勵採用。

目錄

第 1 章：服務概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章：研究方法

  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章：執行摘要

第 4 章：COVID-19 對全球腫瘤資訊系統市場的影響

第 5 章：客戶之聲

第 6 章：全球腫瘤資訊系統市場概述

第 7 章：全球腫瘤資訊系統市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品及服務（軟體、專業服務）
    • 按應用（放射腫瘤學、腫瘤內科、腫瘤外科）
    • 按最終使用者（醫院和腫瘤診所、研究中心、其他）
    • 按地區（北美、歐洲、南美、中東和非洲、亞太地區）
  • 按公司分類 (2022)
  • 市場地圖

第 8 章：北美腫瘤資訊系統市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品和服務
    • 按應用
    • 按最終用戶
    • 按國家/地區

第 9 章：歐洲腫瘤資訊系統市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品和服務
    • 按應用
    • 按最終用戶
    • 按國家/地區

第 10 章：南美洲腫瘤資訊系統市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品和服務
    • 按應用
    • 按最終用戶
    • 按國家/地區

第 11 章：中東和非洲腫瘤資訊系統市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品和服務
    • 按應用
    • 按最終用戶
    • 按國家/地區

第 12 章：亞太地區腫瘤資訊系統市場展望

  • 市場規模及預測
    • 按價值
  • 市場規模及預測
    • 按產品和服務
    • 按應用
    • 按最終用戶
    • 按國家/地區

第 13 章：市場動態

  • 促進要素
  • 挑戰

第 14 章：市場趨勢與發展

第 15 章：公司簡介

  • 醫科達公司
    • Business Overview
    • Key Revenue and Financials
    • Recent Developments
    • Key Personnel
    • Key Product/Services Offered
  • 瓦里安醫療系統公司
    • Business Overview
    • Key Revenue and Financials
    • Recent Developments
    • Key Personnel
    • Key Product/Services Offered
  • 史詩系統公司
    • Business Overview
    • Key Revenue and Financials
    • Recent Developments
    • Key Personnel
    • Key Product/Services Offered
  • 飛利浦醫療保健
    • Business Overview
    • Key Revenue and Financials
    • Recent Developments
    • Key Personnel
    • Key Product/Services Offered
  • 塞納公司
    • Business Overview
    • Key Revenue and Financials
    • Recent Developments
    • Key Personnel
    • Key Product/Services Offered
  • IBM公司
    • Business Overview
    • Key Revenue and Financials
    • Recent Developments
    • Key Personnel
    • Key Product/Services Offered
  • 西門子醫療公司
    • Business Overview
    • Key Revenue and Financials
    • Recent Developments
    • Key Personnel
    • Key Product/Services Offered
  • RaySearch 實驗室AB
    • Business Overview
    • Key Revenue and Financials
    • Recent Developments
    • Key Personnel
    • Key Product/Services Offered
  • 皇家飛利浦公司
    • Business Overview
    • Key Revenue and Financials
    • Recent Developments
    • Key Personnel
    • Key Product/Services Offered
  • 麥克森公司
    • Business Overview
    • Key Revenue and Financials
    • Recent Developments
    • Key Personnel
    • Key Product/Services Offered

第 16 章：策略建議

第 17 章：關於我們與免責聲明

簡介目錄
Product Code: 19583

The Global Oncology Information System (OIS) market is experiencing significant growth and transformation as it plays an increasingly crucial role in modern cancer care. OIS is an integrated software solution designed to manage the complex and multifaceted aspects of oncology treatment and patient data. This market is driven by several key factors, including the rising global cancer burden, the need for more efficient and personalized cancer care, advancements in technology, and the growing importance of data-driven decision-making in healthcare.

OIS systems offer a wide range of functionalities, including patient data management, treatment planning, scheduling, billing, and reporting. They facilitate seamless communication and collaboration among healthcare professionals involved in cancer treatment, leading to more comprehensive and coordinated care. Moreover, OIS solutions enhance the quality and safety of cancer treatments by providing tools for treatment plan validation, dose verification, and quality assurance.

As the demand for improved cancer care continues to rise, OIS systems are becoming integral components of oncology clinics, hospitals, and research institutions worldwide. They support healthcare providers in delivering evidence-based and patient-centered care, ensuring that cancer patients receive the most appropriate and effective treatments. Additionally, OIS platforms contribute to advancements in cancer research by enabling the management of patient data and research findings.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 3.03 Billion
Market Size 2028USD 4.82 Billion
CAGR 2023-20287.16%
Fastest Growing SegmentProfessional Service
Largest MarketNorth America

The market is characterized by a diverse array of vendors offering OIS solutions, ranging from established healthcare IT companies to specialized oncology software providers. These companies compete to innovate and enhance their offerings, introducing features like artificial intelligence, machine learning, and interoperability to further improve the accuracy and efficiency of cancer care.

Key Market Drivers

Rising Cancer Incidence Worldwide:

Cancer remains a major global health concern, with a steady increase in cancer cases. This escalating cancer incidence is a significant driver for the OIS market, as healthcare providers seek advanced solutions to efficiently manage patient data, treatment plans, and outcomes. OIS helps streamline oncology workflows and improve patient care, making it an indispensable tool in the fight against cancer.

Demand for Personalized Cancer Treatment:

Personalized medicine, including targeted therapies and precision oncology, is gaining prominence in cancer care. OIS plays a pivotal role in facilitating the collection and analysis of patient-specific data, such as genetic information and biomarkers. It enables oncologists to tailor treatment plans based on individual patient profiles, leading to more effective and less toxic treatments.

Technological Advancements in Healthcare IT:

The broader healthcare IT landscape is witnessing rapid technological advancements, including the integration of artificial intelligence (AI), machine learning (ML), and big data analytics. OIS providers are leveraging these technologies to enhance cancer diagnosis, treatment planning, and outcome prediction. AI-driven algorithms can assist oncologists in making data-driven decisions and identifying treatment options.

Increasing Emphasis on Data-Driven Medicine:

Data-driven decision-making is becoming increasingly essential in healthcare, particularly in oncology. OIS offers comprehensive tools for data management and analysis, allowing healthcare professionals to derive valuable insights from patient data. This data-centric approach is crucial for improving clinical outcomes, conducting research, and optimizing resource allocation.

Growing Oncology Research and Clinical Trials:

Oncology research and clinical trials are expanding to discover novel therapies and interventions. OIS plays a critical role in facilitating the management of patient data for clinical trials, helping researchers efficiently collect, analyze, and report clinical data. This drives the adoption of OIS solutions by research institutions, pharmaceutical companies, and healthcare providers participating in clinical trials.

Key Market Challenges

Data Security and Privacy Concerns:

In the oncology field, patient data is highly sensitive and must be protected. The challenge lies in ensuring robust data security and privacy compliance while making these systems accessible to healthcare providers. Striking the right balance between accessibility and security is an ongoing challenge.

Interoperability and Data Integration:

OIS often need to integrate with various healthcare systems, such as electronic health records (EHRs), radiology information systems (RIS), and laboratory information systems (LIS). Achieving seamless interoperability and data integration between these systems is a significant challenge, as it requires adherence to diverse data standards and protocols.

Cost and Resource Constraints:

Implementing and maintaining advanced OIS can be financially demanding for healthcare institutions, particularly smaller clinics and facilities with limited budgets. Balancing the need for cutting-edge OIS capabilities with budget constraints is an ongoing challenge.

Regulatory Compliance:

The healthcare sector is subject to numerous regulations and compliance requirements, including those related to patient data protection (e.g., HIPAA in the United States). OIS providers and healthcare institutions must continuously monitor and adapt to evolving regulatory frameworks, which can be complex and vary by region.

Integration of Emerging Technologies:

OIS must stay abreast of the rapid evolution of healthcare technology, including artificial intelligence (AI), machine learning (ML), and genomics. Integrating these emerging technologies effectively while ensuring their clinical validity poses a challenge. Additionally, training healthcare professionals to use these advanced tools is critical.

Key Market Trends

Integration of AI and Machine Learning (ML):

AI and ML are revolutionizing oncology information systems by analyzing vast patient data sets to identify trends, predict outcomes, and optimize treatment plans. These technologies assist oncologists in making data-driven decisions, enhancing patient care, and improving treatment effectiveness.

Telemedicine and Remote Monitoring:

The COVID-19 pandemic accelerated the adoption of telemedicine and remote monitoring in oncology. Oncology information systems are now equipped with telehealth features, allowing patients to consult with oncologists remotely. This trend ensures continuous care and minimizes disruptions, especially for patients undergoing long-term treatments.

Personalized Medicine and Genomic Data Integration:

Advancements in genomics have led to the growth of personalized medicine in oncology. Oncology information systems now integrate genomic data to tailor treatment plans based on a patient's genetic profile. This approach enhances treatment efficacy and minimizes adverse effects.

Cloud-Based Solutions and Data Accessibility:

Cloud-based oncology information systems provide secure storage, easy accessibility, and seamless data sharing among healthcare providers. This trend promotes collaboration, reduces infrastructure costs, and ensures that patient data remains up-to-date and accessible from anywhere.

Patient Engagement and Survivorship Care Plans:

Increasingly, oncology information systems are incorporating features to engage patients actively in their care. Survivorship care plans are gaining importance to help patients transition from treatment to follow-up care seamlessly. These plans also empower patients with information and resources for long-term survivorship.

Segmental Insights

Product & Services Insights

Software segment dominates in the global oncology information system market in 2022. OIS software is designed to efficiently collect, store, and manage vast amounts of patient data critical for oncology treatment. This includes patient medical histories, imaging data (such as MRIs and CT scans), laboratory results, and treatment plans. The ability to centralize and access this information in real-time enhances clinical decision-making.

OIS software offers sophisticated treatment planning tools that assist oncologists in creating tailored treatment regimens for patients. These systems use advanced algorithms to analyze patient data, helping healthcare providers determine the most appropriate therapies and interventions. Treatment planning is essential in improving treatment efficacy and minimizing side effects.

OIS software streamlines oncology workflows by automating administrative tasks, appointment scheduling, and data entry. This efficiency allows healthcare professionals to focus more on patient care and less on paperwork, ultimately enhancing productivity.

OIS software seamlessly integrates with other healthcare IT systems, such as electronic health records (EHRs) and radiology information systems (RIS), ensuring the seamless flow of information across different departments within a healthcare facility. This integration enhances care coordination and reduces the risk of errors.

OIS software provides robust data analytics and reporting capabilities. It allows healthcare providers to track patient outcomes, assess treatment effectiveness, and conduct research. Analyzing trends and patterns in cancer care can lead to continuous improvements in treatment protocols.

Application Insights

Radiation oncology segment dominates in the global oncology information system market in 2022. Radiation therapy plays a critical role in the treatment of cancer, and precision is paramount. OIS systems within the Radiation Oncology segment are specifically designed to ensure accurate treatment planning. They incorporate advanced imaging technologies, such as CT scans and MRI, to precisely target tumors while minimizing damage to surrounding healthy tissues. This level of precision is essential in radiation therapy.

OIS solutions for Radiation Oncology enable the development of highly personalized treatment plans tailored to each patient's unique anatomy and condition. They consider factors like tumor size, location, and response to previous treatments, ensuring that radiation therapy is optimized for maximum effectiveness.

Radiation therapy relies on calculating the optimal radiation dose to eradicate cancer cells while sparing healthy tissue. OIS software excels in dose calculation and optimization, ensuring that patients receive the right amount of radiation to achieve therapeutic goals with minimal side effects.

The Radiation Oncology segment includes features for real-time treatment monitoring and delivery. OIS systems offer safeguards to verify that the prescribed radiation dose is accurately delivered during each treatment session, providing peace of mind to both patients and clinicians.

Patient safety is paramount in radiation oncology. OIS solutions within this segment incorporate safety checks and quality assurance protocols to minimize the risk of errors during treatment. They also facilitate adherence to strict regulatory standards and guidelines.

Radiation Oncology OIS software seamlessly integrates with imaging systems such as PET/CT, MRI, and linear accelerators. This integration ensures that treatment plans are based on the most up-to-date patient data and imaging results, enhancing the precision of radiation therapy.

Regional Insights

North America dominates the Global Oncology Information System Market in 2022. North America boasts a highly developed and technologically advanced healthcare infrastructure. The region is home to some of the world's leading cancer treatment centers, research institutions, and healthcare facilities. The availability of state-of-the-art equipment and a skilled workforce has made it a fertile ground for the adoption of OIS.

North America has a relatively high incidence of cancer. According to the American Cancer Society, cancer is one of the leading causes of death in the United States. The prevalence of cancer in the region has prompted healthcare providers to invest in advanced solutions like OIS to efficiently manage patient data, treatment plans, and outcomes.

North America has been at the forefront of the personalized medicine movement, which tailors cancer treatments to individual patient profiles. OIS plays a crucial role in collecting and analyzing patient-specific data, including genetic information and biomarkers, to guide personalized treatment decisions. The region's commitment to advancing personalized medicine has driven the demand for OIS solutions.

North America hosts a significant portion of global oncology research and clinical trials. Academic institutions, pharmaceutical companies, and healthcare providers in the region actively participate in clinical research. OIS facilitates the management of patient data for clinical trials, making it an indispensable tool for researchers and institutions involved in cancer studies.

North America has well-established regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and Health Canada, which provide clear guidelines and regulations for healthcare IT systems like OIS. The regulatory framework ensures the safety and effectiveness of OIS solutions, instilling confidence in healthcare providers and encouraging adoption.

Key Market Players

Elekta AB

Varian Medical Systems, Inc.

Epic Systems Corporation

Philips Healthcare

Cerner Corporation

IBM Corporation

Siemens Healthineers

RaySearch Laboratories AB

Koninklijke Philips N.V.

McKesson Corporation

Report Scope:

In this report, the Global Oncology Information System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Oncology Information System Market, By Product & Services:

  • Software
  • Professional Service

Oncology Information System Market, By Application:

  • Radiation Oncology
  • Medical Oncology
  • Surgical Oncology

Oncology Information System Market, By End User:

  • Hospital & Oncology Clinic
  • Research Center
  • Others

Oncology Information System Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Oncology Information System Market.

Available Customizations:

  • Global Oncology Information System Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Service Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Baseline Methodology
  • 2.2. Key Industry Partners
  • 2.3. Major Association and Secondary Sources
  • 2.4. Forecasting Methodology
  • 2.5. Data Triangulation & Validation
  • 2.6. Assumptions and Limitations

3. Executive Summary

4. Impact of COVID-19 on Global Oncology Information System Market

5. Voice of Customer

6. Global Oncology Information System Market Overview

7. Global Oncology Information System Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product & Services (Software, Professional Service)
    • 7.2.2. By Application (Radiation Oncology, Medical Oncology, Surgical Oncology)
    • 7.2.3. By End User (Hospital & Oncology Clinic, Research Center, Others)
    • 7.2.4. By Region (North America, Europe, South America, Middle East & Africa, Asia Pacific)
  • 7.3. By Company (2022)
  • 7.4. Market Map

8. North America Oncology Information System Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product & Services
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
      • 8.2.4.1. United States Oncology Information System Market Outlook
        • 8.2.4.1.1. Market Size & Forecast
        • 8.2.4.1.1.1. By Value
        • 8.2.4.1.2. Market Share & Forecast
        • 8.2.4.1.2.1. By Product & Services
        • 8.2.4.1.2.2. By Application
        • 8.2.4.1.2.3. By End User
      • 8.2.4.2. Canada Oncology Information System Market Outlook
        • 8.2.4.2.1. Market Size & Forecast
        • 8.2.4.2.1.1. By Value
        • 8.2.4.2.2. Market Share & Forecast
        • 8.2.4.2.2.1. By Product & Services
        • 8.2.4.2.2.2. By Application
        • 8.2.4.2.2.3. By End User
      • 8.2.4.3. Mexico Oncology Information System Market Outlook
        • 8.2.4.3.1. Market Size & Forecast
        • 8.2.4.3.1.1. By Value
        • 8.2.4.3.2. Market Share & Forecast
        • 8.2.4.3.2.1. By Product & Services
        • 8.2.4.3.2.2. By Application
        • 8.2.4.3.2.3. By End User

9. Europe Oncology Information System Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product & Services
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
      • 9.2.4.1. Germany Oncology Information System Market Outlook
        • 9.2.4.1.1. Market Size & Forecast
        • 9.2.4.1.1.1. By Value
        • 9.2.4.1.2. Market Share & Forecast
        • 9.2.4.1.2.1. By Product & Services
        • 9.2.4.1.2.2. By Application
        • 9.2.4.1.2.3. By End User
      • 9.2.4.2. France Oncology Information System Market Outlook
        • 9.2.4.2.1. Market Size & Forecast
        • 9.2.4.2.1.1. By Value
        • 9.2.4.2.2. Market Share & Forecast
        • 9.2.4.2.2.1. By Product & Services
        • 9.2.4.2.2.2. By Application
        • 9.2.4.2.2.3. By End User
      • 9.2.4.3. United Kingdom Oncology Information System Market Outlook
        • 9.2.4.3.1. Market Size & Forecast
        • 9.2.4.3.1.1. By Value
        • 9.2.4.3.2. Market Share & Forecast
        • 9.2.4.3.2.1. By Product & Services
        • 9.2.4.3.2.2. By Application
        • 9.2.4.3.2.3. By End User
      • 9.2.4.4. Italy Oncology Information System Market Outlook
        • 9.2.4.4.1. Market Size & Forecast
        • 9.2.4.4.1.1. By Value
        • 9.2.4.4.2. Market Share & Forecast
        • 9.2.4.4.2.1. By Product & Services
        • 9.2.4.4.2.2. By Application
        • 9.2.4.4.2.3. By End User
      • 9.2.4.5. Spain Oncology Information System Market Outlook
        • 9.2.4.5.1. Market Size & Forecast
        • 9.2.4.5.1.1. By Value
        • 9.2.4.5.2. Market Share & Forecast
        • 9.2.4.5.2.1. By Product & Services
        • 9.2.4.5.2.2. By Application
        • 9.2.4.5.2.3. By End User

10. South America Oncology Information System Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product & Services
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
      • 10.2.4.1. Brazil Oncology Information System Market Outlook
        • 10.2.4.1.1. Market Size & Forecast
        • 10.2.4.1.1.1. By Value
        • 10.2.4.1.2. Market Share & Forecast
        • 10.2.4.1.2.1. By Product & Services
        • 10.2.4.1.2.2. By Application
        • 10.2.4.1.2.3. By End User
      • 10.2.4.2. Colombia Oncology Information System Market Outlook
        • 10.2.4.2.1. Market Size & Forecast
        • 10.2.4.2.1.1. By Value
        • 10.2.4.2.2. Market Share & Forecast
        • 10.2.4.2.2.1. By Product & Services
        • 10.2.4.2.2.2. By Application
        • 10.2.4.2.2.3. By End User
      • 10.2.4.3. Argentina Oncology Information System Market Outlook
        • 10.2.4.3.1. Market Size & Forecast
        • 10.2.4.3.1.1. By Value
        • 10.2.4.3.2. Market Share & Forecast
        • 10.2.4.3.2.1. By Product & Services
        • 10.2.4.3.2.2. By Application
        • 10.2.4.3.2.3. By End User

11. Middle East & Africa Oncology Information System Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product & Services
    • 11.2.2. By Application
    • 11.2.3. By End User
    • 11.2.4. By Country
      • 11.2.4.1. Saudi Arabia Oncology Information System Market Outlook
        • 11.2.4.1.1. Market Size & Forecast
        • 11.2.4.1.1.1. By Value
        • 11.2.4.1.2. Market Share & Forecast
        • 11.2.4.1.2.1. By Product & Services
        • 11.2.4.1.2.2. By Application
        • 11.2.4.1.2.3. By End User
      • 11.2.4.2. UAE Oncology Information System Market Outlook
        • 11.2.4.2.1. Market Size & Forecast
        • 11.2.4.2.1.1. By Value
        • 11.2.4.2.2. Market Share & Forecast
        • 11.2.4.2.2.1. By Product & Services
        • 11.2.4.2.2.2. By Application
        • 11.2.4.2.2.3. By End User
      • 11.2.4.3. South Africa Oncology Information System Market Outlook
        • 11.2.4.3.1. Market Size & Forecast
        • 11.2.4.3.1.1. By Value
        • 11.2.4.3.2. Market Share & Forecast
        • 11.2.4.3.2.1. By Product & Services
        • 11.2.4.3.2.2. By Application
        • 11.2.4.3.2.3. By End User

12. Asia Pacific Oncology Information System Market Outlook

  • 12.1. Market Size & Forecast
    • 12.1.1. By Value
  • 12.2. Market Size & Forecast
    • 12.2.1. By Product & Services
    • 12.2.2. By Application
    • 12.2.3. By End User
    • 12.2.4. By Country
      • 12.2.4.1. China Oncology Information System Market Outlook
        • 12.2.4.1.1. Market Size & Forecast
        • 12.2.4.1.1.1. By Value
        • 12.2.4.1.2. Market Share & Forecast
        • 12.2.4.1.2.1. By Product & Services
        • 12.2.4.1.2.2. By Application
        • 12.2.4.1.2.3. By End User
      • 12.2.4.2. India Oncology Information System Market Outlook
        • 12.2.4.2.1. Market Size & Forecast
        • 12.2.4.2.1.1. By Value
        • 12.2.4.2.2. Market Share & Forecast
        • 12.2.4.2.2.1. By Product & Services
        • 12.2.4.2.2.2. By Application
        • 12.2.4.2.2.3. By End User
      • 12.2.4.3. Japan Oncology Information System Market Outlook
        • 12.2.4.3.1. Market Size & Forecast
        • 12.2.4.3.1.1. By Value
        • 12.2.4.3.2. Market Share & Forecast
        • 12.2.4.3.2.1. By Product & Services
        • 12.2.4.3.2.2. By Application
        • 12.2.4.3.2.3. By End User
      • 12.2.4.4. South Korea Oncology Information System Market Outlook
        • 12.2.4.4.1. Market Size & Forecast
        • 12.2.4.4.1.1. By Value
        • 12.2.4.4.2. Market Share & Forecast
        • 12.2.4.4.2.1. By Product & Services
        • 12.2.4.4.2.2. By Application
        • 12.2.4.4.2.3. By End User
      • 12.2.4.5. Australia Oncology Information System Market Outlook
        • 12.2.4.5.1. Market Size & Forecast
        • 12.2.4.5.1.1. By Value
        • 12.2.4.5.2. Market Share & Forecast
        • 12.2.4.5.2.1. By Product & Services
        • 12.2.4.5.2.2. By Application
        • 12.2.4.5.2.3. By End User

13. Market Dynamics

  • 13.1. Drivers
  • 13.2. Challenges

14. Market Trends and Developments

15. Company Profiles

  • 15.1. Elekta AB
    • 15.1.1. Business Overview
    • 15.1.2. Key Revenue and Financials
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. Key Product/Services Offered
  • 15.2. Varian Medical Systems, Inc.
    • 15.2.1. Business Overview
    • 15.2.2. Key Revenue and Financials
    • 15.2.3. Recent Developments
    • 15.2.4. Key Personnel
    • 15.2.5. Key Product/Services Offered
  • 15.3. Epic Systems Corporation
    • 15.3.1. Business Overview
    • 15.3.2. Key Revenue and Financials
    • 15.3.3. Recent Developments
    • 15.3.4. Key Personnel
    • 15.3.5. Key Product/Services Offered
  • 15.4. Philips Healthcare
    • 15.4.1. Business Overview
    • 15.4.2. Key Revenue and Financials
    • 15.4.3. Recent Developments
    • 15.4.4. Key Personnel
    • 15.4.5. Key Product/Services Offered
  • 15.5. Cerner Corporation
    • 15.5.1. Business Overview
    • 15.5.2. Key Revenue and Financials
    • 15.5.3. Recent Developments
    • 15.5.4. Key Personnel
    • 15.5.5. Key Product/Services Offered
  • 15.6. IBM Corporation
    • 15.6.1. Business Overview
    • 15.6.2. Key Revenue and Financials
    • 15.6.3. Recent Developments
    • 15.6.4. Key Personnel
    • 15.6.5. Key Product/Services Offered
  • 15.7. Siemens Healthineers
    • 15.7.1. Business Overview
    • 15.7.2. Key Revenue and Financials
    • 15.7.3. Recent Developments
    • 15.7.4. Key Personnel
    • 15.7.5. Key Product/Services Offered
  • 15.8. RaySearch Laboratories AB
    • 15.8.1. Business Overview
    • 15.8.2. Key Revenue and Financials
    • 15.8.3. Recent Developments
    • 15.8.4. Key Personnel
    • 15.8.5. Key Product/Services Offered
  • 15.9. Koninklijke Philips N.V.
    • 15.9.1. Business Overview
    • 15.9.2. Key Revenue and Financials
    • 15.9.3. Recent Developments
    • 15.9.4. Key Personnel
    • 15.9.5. Key Product/Services Offered
  • 15.10. McKesson Corporation
    • 15.10.1. Business Overview
    • 15.10.2. Key Revenue and Financials
    • 15.10.3. Recent Developments
    • 15.10.4. Key Personnel
    • 15.10.5. Key Product/Services Offered

16. Strategic Recommendations

17. About Us & Disclaimer